108 results
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
7 May 24
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
7:03am
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
9 Apr 24
Regulation FD Disclosure
4:30pm
-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this presentation
S-3ASR
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and our stockholders
8-K
EX-99.1
j2ulpkg 0rzrjt0ruv
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
075f 2ioggt5qpt3r
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
EX-99.1
qsu7ta8us gp33
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
q6mej
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
EX-99.2
0wya8 n7y2
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
EX-99.1
waen9ggyqpwup3pftz
13 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
opn1wudq
9 Aug 23
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
q9g0q91geenn
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
424B5
m31o8
15 Jun 23
Prospectus supplement for primary offering
4:12pm
FWP
d9dynputv 4onngzc
15 Jun 23
Free writing prospectus
7:03am